Abstract: Pure form of L-Dopa is used to enhance muscular development, fat breakdown and suppress Parkinson disease in humans. However, the L-Dopa in mucuna seed, when present with other antinutritional factors, causes nutritional disorders in monogastric animals. Information on the utilisation of pure L-Dopa in monogastric animals is scanty. Therefore, effect of L-Dopa on growth performance and carcass characteristics in broiler chickens was investigated. Two hundred and forty one-day-old chicks were allotted to six treatments, which consisted of a positive control (PC) with standard energy (3100Kcal/Kg) and negative control (NC) with high energy (3500Kcal/Kg). The rest 4 diets were NC+0.1, NC+0.2, NC+0.3 and NC+0.4% L-Dopa, respectively. All treatments had 4 replicates in a completely randomized design. Body weight gain, final weight, feed intake, dressed weight and carcass characteristics were determined. Body weight gain and final weight of birds fed PC were 1791.0 and 1830.0g, NC+0.1% L-Dopa were 1827.7 and 1866.7g and NC+0.2% L-Dopa were 1871.9 and 1910.9g respectively, and the feed intake of PC (3231.5g), were better than other treatments. The dressed weight at 1375.0g and 1357.1g of birds fed NC+0.1% and NC+0.2% L-Dopa, respectively, were similar but better than other treatments. Also, the thigh (202.5g and 194.9g) and the breast meat (413.8g and 410.8g) of birds fed NC+0.1% and NC+0.2% L-Dopa, respectively, were similar but better than birds fed other treatments. The drum stick of birds fed NC+0.1% L-Dopa (220.5g) was observed to be better than birds on other diets. Meat to bone ratio and relative organ weights were not affected across treatments. L-Dopa extract, at levels tested, had no detrimental effect on broilers, rather better bird performance and carcass characteristics were observed especially at 0.1% and 0.2% L-Dopa inclusion rates. Therefore, 0.2% inclusion is recommended in diets of broiler chickens for improved performance and carcass characteristics.
Abstract: Dietary cholesterol has elicited the most public
interest as it relates with coronary heart disease. Thus, humans have
been paying more attention to health, thereby reducing consumption
of cholesterol enriched food. Egg is considered as one of the major
sources of human dietary cholesterol. However, an alternative way to
reduce the potential cholesterolemic effect of eggs is to modify the
fatty acid composition of the yolk. The effect of palm oil (PO),
soybean oil (SO), sesame seed oil (SSO) and fish oil (FO)
supplementation in the diets of layers on egg yolk fatty acid,
cholesterol, egg production and egg quality parameters were
evaluated in a 42-day feeding trial. One hundred and five Isa Brown
laying hens of 34 weeks of age were randomly distributed into seven
groups of five replicates and three birds per replicate in a completely
randomized design. Seven corn-soybean basal diets (BD) were
formulated: BD+No oil (T1), BD+1.5% PO (T2), BD+1.5% SO (T3),
BD+1.5% SSO (T4), BD+1.5% FO (T5), BD+0.75% SO+0.75% FO
(T6) and BD+0.75% SSO+0.75% FO (T7). Five eggs were randomly
sampled at day 42 from each replicate to assay for the cholesterol,
fatty acid profile of egg yolk and egg quality assessment. Results
showed that there were no significant (P>0.05) differences observed
in production performance, egg cholesterol and egg quality
parameters except for yolk height, albumen height, yolk index, egg
shape index, haugh unit, and yolk colour. There were no significant
differences (P>0.05) observed in total cholesterol, high density
lipoprotein and low density lipoprotein levels of egg yolk across the
treatments. However, diets had effect (P